CDK9-IN-27

• Target:

  CDK

• Related Pathways:

  Cell Cycle/Checkpoint

• Bioactivity:

  CDK9-IN-27 (Compound 6a), a CDK9 inhibitor with an IC50 of 0.424 ?M, induces apoptosis and S-phase cell cycle arrest. It exhibits cytotoxicity against HepG2, HCT-116, and MCF-7 cell lines, with IC50 values ranging from 10.31 to 40.34 ?M, rendering it applicable in cancer research [1].

• Molecular Formula:

  C23H18ClN5O3

• Molecular Weight:

  447.87

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C